End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.15 CNY | +2.42% | +0.93% | +8.97% |
Apr. 24 | Livzon Pharmaceutical's Q1 Profit Jumps 4.5%; Revenue Slips 5% | MT |
Apr. 23 | Livzon Pharmaceutical Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 8,933
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chemical Agents
52.9
%
| 7,000 | 55.4 % | 6,571 | 52.9 % | -6.13% |
APIs and Intermediates
26.2
%
| 3,138 | 24.8 % | 3,253 | 26.2 % | +3.66% |
Traditional Chinese Medicine
14.0
%
| 1,254 | 9.9 % | 1,745 | 14.0 % | +39.19% |
Diagnostic Reagents and Equipment
5.3
%
| 724 | 5.7 % | 659 | 5.3 % | -8.92% |
Biological
0.7
%
| 408 | 3.2 % | 84 | 0.7 % | -79.33% |
Other Business
0.4
%
| 42 | 0.3 % | 49 | 0.4 % | +18.26% |
Sales Materials, Processing Fees, Etc.
0.4
%
| - | - | 46 | 0.4 % | - |
Others
0.1
%
| - | - | 14 | 0.1 % | - |
Rental
0.1
%
| 7 | 0.1 % | 9 | 0.1 % | +29.96% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
87.3
%
| 10,959 | 87.5 % | 10,754 | 87.3 % | -1.86% |
Overseas
12.7
%
| 1,565 | 12.5 % | 1,571 | 12.7 % | +0.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yang Gang Tang
PSD | President | 55 | 18-07-16 |
Yan Xia Si
DFI | Director of Finance/CFO | 56 | 93-03-31 |
Maolin Wang
CHM | Chairman | 59 | 00-12-31 |
Bao Guo Zhu
CHM | Chairman | 62 | 01-12-31 |
Guo Xiang Xu
BRD | Director/Board Member | 61 | 07-02-28 |
De Sheng Tao
BRD | Director/Board Member | 60 | 84-12-31 |
De Long Ye
IRC | Investor Relations Contact | - | - |
Yu Xuan Huang
PRN | Corporate Officer/Principal | 57 | 18-10-24 |
Dai Hong Yang
PRN | Corporate Officer/Principal | 58 | 96-12-31 |
Liang Yang
SEC | Corporate Secretary | 41 | 11-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bao Guo Zhu
CHM | Chairman | 62 | 01-12-31 |
Qiu Sheng Tian
BRD | Director/Board Member | 68 | 19-10-14 |
Hua Min Huang
BRD | Director/Board Member | 53 | 13-05-31 |
Maolin Wang
CHM | Chairman | 59 | 00-12-31 |
De Sheng Tao
BRD | Director/Board Member | 60 | 84-12-31 |
Guo Xiang Xu
BRD | Director/Board Member | 61 | 07-02-28 |
Xiong Yu
BRD | Director/Board Member | 63 | 13-08-31 |
Hua Bai
BRD | Director/Board Member | 55 | 20-06-29 |
Yang Gang Tang
PSD | President | 55 | 18-07-16 |
Li Jie Cui
BRD | Director/Board Member | 48 | 21-07-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 310,011,513 | 0 | 2,476,300 ( 0.7988 %) | 38.37 % |
Stock B | 1 | 616,633,231 | 355,585,724 ( 57.67 %) | 2,152,600 ( 0.3491 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
5,829,048 | 0.96% | 29,437,800 $ |
Company contact information
Livzon Pharmaceutical Group, Inc.
Headquarters Building 38 Chuangye North Road
519090, Zhuhai
+86 75 6813 5888
http://www.livzon.com.cnSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.97% | 4.25B | |
+25.61% | 660B | |
+22.70% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.74% | 219B | |
-9.78% | 196B | |
+6.61% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- 000513 Stock
- Company Livzon Pharmaceutical Group Inc.